- Home
- ICCM vs VATE Comparison
ICCM vs VATE Comparison
Compare ICCM & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- VATE
- Stock Information
- Founded
- ICCM 2006
- VATE 1994
- Country
- ICCM Israel
- VATE United States
- Employees
- ICCM N/A
- VATE N/A
- Industry
- ICCM
- VATE Metal Fabrications
- Sector
- ICCM
- VATE Industrials
- Exchange
- ICCM Nasdaq
- VATE Nasdaq
- Market Cap
- ICCM 61.1M
- VATE 62.0M
- IPO Year
- ICCM N/A
- VATE 1996
- Fundamental
- Price
- ICCM $0.98
- VATE $4.32
- Analyst Decision
- ICCM Strong Buy
- VATE
- Analyst Count
- ICCM 1
- VATE 0
- Target Price
- ICCM $2.50
- VATE N/A
- AVG Volume (30 Days)
- ICCM 2.5M
- VATE 43.4K
- Earning Date
- ICCM 11-25-2025
- VATE 11-05-2025
- Dividend Yield
- ICCM N/A
- VATE N/A
- EPS Growth
- ICCM N/A
- VATE N/A
- EPS
- ICCM N/A
- VATE N/A
- Revenue
- ICCM $2,787,000.00
- VATE $995,000,000.00
- Revenue This Year
- ICCM $3.95
- VATE N/A
- Revenue Next Year
- ICCM $266.15
- VATE N/A
- P/E Ratio
- ICCM N/A
- VATE N/A
- Revenue Growth
- ICCM N/A
- VATE N/A
- 52 Week Low
- ICCM $0.48
- VATE $3.35
- 52 Week High
- ICCM $1.66
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- ICCM 46.89
- VATE 39.51
- Support Level
- ICCM $0.93
- VATE $4.53
- Resistance Level
- ICCM $1.40
- VATE $4.80
- Average True Range (ATR)
- ICCM 0.07
- VATE 0.33
- MACD
- ICCM -0.01
- VATE -0.04
- Stochastic Oscillator
- ICCM 12.45
- VATE 8.60
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.